This page includes Regulatory news filings supplied by issuers listed on the BSX. Please note the BSX is not responsible for the content, accuracy or completeness of announcements filed by issuers and disclaims all liability for any loss arising from reliance on information contained within issuer announcements.
Partial Redemption of Jazz Pharmaceuticals UK Holding Limited
Hamilton, Bermuda: November 20, 2025 – The Bermuda Stock Exchange announces that the issuer of the following security admitted to its Official List under Listing Regulations Section IIIB – International Issuers – Debt Securities has partially redeemed the security under Listing Regulation 6.8:
· Name of Issuer: - Jazz Pharmaceuticals UK Holding Limited
· Description of Securities: - International Debt
· Maturity Date: - January 15, 2029
· Amount Outstanding: - 2,960,000,000
With the amount outstanding being reduced as follows:
· Name of Issuer: - Jazz Pharmaceuticals UK Holding Limited
· Description of Securities: - International Debt
· Maturity Date: - January 15, 2029
· New Amount Outstanding: - 2,128,400,000
# # # #
About BSX
The Bermuda Stock Exchange (BSX), a wholly owned subsidiary of Miami International Holdings, Inc., is a fully electronic, vertically integrated international securities market headquartered in Bermuda and organised in 1971. BSX specialises in the listing and trading of capital market instruments such as equities, debt issues, funds, hedge funds, derivative warrants, and insurance linked securities. To learn more about BSX visit bsx.com or contact info@bsx.com